Stage 3 breast cancer, also known as locally advanced breast cancer, represents a significant but treatable diagnosis where the cancer has spread beyond the breast itself to nearby lymph nodes or tissues. Understanding how this stage is identified and confirmed through various diagnostic tests helps patients and their families prepare for treatment decisions and what lies ahead.

Introduction: Who Should Undergo Diagnostics

When doctors suspect stage 3 breast cancer, a thorough diagnostic process becomes essential. This stage is characterized by cancer that has moved beyond the breast tissue to involve nearby lymph nodes or has grown into the skin or chest wall, but has not yet spread to distant organs in the body.^[1] Anyone who notices warning signs such as a lump in the breast that feels attached to the chest wall, thickened or dimpled skin resembling an orange peel, ulcerated or broken-down skin on the breast, unusual swelling or redness, a large lump in the armpit, or a lump at the base of the neck should seek medical evaluation promptly.^[5]

The diagnostic journey typically begins after initial screening finds something suspicious, or when a person discovers worrying symptoms during self-examination. At this point, the medical team needs to determine not just whether cancer is present, but how far it has spread, what type of cancer cells are involved, and what specific characteristics they have. This information shapes every decision about treatment that follows.^[2]

Women who have already been treated for earlier-stage breast cancer should also remain vigilant, as they need regular monitoring to catch any recurrence early. Similarly, those with a family history of breast cancer or known genetic mutations may benefit from more frequent diagnostic evaluations, even without obvious symptoms.^[14]

Diagnostic Methods for Identifying Stage 3 Breast Cancer

The process of diagnosing stage 3 breast cancer involves multiple types of tests working together to create a complete picture. These tests help doctors understand the size of the tumor, whether it has spread to lymph nodes, and if it has affected surrounding tissues like the chest wall or skin.

Physical Examination

The diagnostic journey often begins with a thorough physical examination by a healthcare provider. During this exam, the doctor carefully feels the breast tissue, checking for lumps, areas of thickness, or changes in texture. They also examine the skin for any dimpling, redness, or ulceration. The armpit area receives special attention because this is where lymph nodes that drain the breast are located. Large or firm lymph nodes in the armpit can be an important sign that cancer has spread beyond the breast itself.^[5]

The doctor also checks for signs that the cancer may have grown into the chest wall by assessing whether any breast lumps move freely or seem attached to deeper structures. They examine the area above and below the collarbone for enlarged lymph nodes, as involvement of these nodes indicates more advanced disease.^[2]

Imaging Studies

Several types of imaging tests help visualize the cancer and determine its extent. A diagnostic mammogram provides detailed X-ray images of the breast tissue, showing the tumor’s size and location more clearly than a screening mammogram. However, mammograms alone cannot determine if cancer has spread to lymph nodes or other nearby structures.^[6]

Ultrasound uses sound waves to create images of breast tissue and nearby lymph nodes. This test is particularly useful for examining lumps found during physical examination and for checking lymph nodes in the armpit to see if they appear abnormal. Ultrasound can help distinguish between fluid-filled cysts and solid masses, and it guides needles during biopsy procedures.^[7]

Magnetic Resonance Imaging (MRI) of the breast provides extremely detailed images and can sometimes detect cancer that other imaging tests miss. MRI is especially helpful for examining dense breast tissue and for determining the exact size and extent of the cancer. It can reveal multiple tumors in the same breast or cancer in the opposite breast that wasn’t initially suspected.^[7]

For stage 3 breast cancer, doctors often recommend additional imaging to check if the cancer has spread beyond the breast and nearby lymph nodes. A chest X-ray or CT scan examines the lungs, a common site for breast cancer to spread. Bone scans use small amounts of radioactive material to highlight areas where cancer might have spread to the bones. These tests help confirm that the cancer is truly stage 3 and has not progressed to stage 4, which involves distant spread to other organs.^[6]

Tissue Biopsy

A biopsy is the only way to definitively confirm that cancer is present and to determine what type of cancer it is. During a breast biopsy, a small sample of tissue is removed from the suspicious area and examined under a microscope by a pathologist. There are several types of biopsies, including fine needle aspiration, core needle biopsy, and surgical biopsy. Core needle biopsy is most commonly used because it removes a larger tissue sample that provides more information about the cancer’s characteristics.^[7]

If lymph nodes appear enlarged or abnormal on imaging or physical exam, doctors may also perform a lymph node biopsy. This can be done with a needle or during surgery. The tissue from lymph nodes is examined to determine whether cancer cells have spread there, which is a defining feature of stage 3 breast cancer.^[2]

Laboratory Tests on Cancer Tissue

Once cancer tissue is obtained through biopsy, several important laboratory tests are performed on the sample. These tests identify specific characteristics of the cancer cells that guide treatment decisions.

Hormone receptor testing determines whether the cancer cells have receptors for estrogen or progesterone on their surface. Cancers that are hormone receptor-positive grow in response to these hormones, and patients with these cancers can benefit from hormone-blocking therapies. Approximately 70% of breast cancers are hormone receptor-positive.^[10]

HER2 testing checks whether the cancer cells produce too much of a protein called HER2, which promotes cancer cell growth. About 20% of breast cancers are HER2-positive, and these cancers tend to grow more quickly but can be treated with targeted therapies that specifically block HER2.^[11]

The tumor grade describes how abnormal the cancer cells look under the microscope and how quickly they appear to be growing. Grade 1 tumors look more like normal breast tissue and tend to grow slowly, while grade 3 tumors look very abnormal and grow more rapidly.^[2]

Understanding Stage 3 Subdivisions

Stage 3 breast cancer is divided into three subcategories—3A, 3B, and 3C—based on the combination of tumor size, lymph node involvement, and spread to nearby tissues. Stage 3A means either that no cancer is seen in the breast or the cancer is any size, with cancer present in 4 to 9 lymph nodes under the arm or near the breastbone, or the cancer is larger than 5 centimeters and has spread to 1 to 3 lymph nodes.^[2]

Stage 3B indicates that the cancer has spread to the skin of the breast or the chest wall, which includes the ribs, muscles, and connective tissues. The cancer may have caused the skin to break down into an ulcer or caused swelling. It may have spread to up to 9 lymph nodes. This stage also includes inflammatory breast cancer, a rare but aggressive form where the breast appears red and swollen.^[2]

Stage 3C represents the most advanced locally advanced breast cancer. The cancer can be any size or may not even be visible in the breast, but it has spread to 10 or more lymph nodes in the armpit, to lymph nodes above or below the collarbone, or to lymph nodes both in the armpit and near the breastbone. The cancer may also have grown into the chest wall or skin.^[2]

TNM Staging System

Doctors also use something called the TNM staging system to classify breast cancer. TNM stands for Tumor, Node, and Metastasis. The T describes the size of the primary tumor in the breast, the N describes how many and which lymph nodes contain cancer, and the M indicates whether the cancer has metastasized or spread to distant organs. Each letter is given a number that provides more specific information.^[6]

For example, a very small cancer that hasn’t spread might be classified as T1 N0 M0, while a stage 3 cancer might be T3 N2 M0, meaning a larger tumor with several involved lymph nodes but no distant spread. Understanding this system helps ensure that everyone on your healthcare team is communicating clearly about the extent of your disease.^[2]

Diagnostics for Clinical Trial Qualification

When considering enrollment in a clinical trial for stage 3 breast cancer, patients typically undergo additional diagnostic evaluations beyond those used for standard diagnosis. Clinical trials have specific eligibility criteria, and diagnostic tests help determine whether a patient meets these requirements.

Confirming Stage and Extent of Disease

Clinical trials for stage 3 breast cancer require precise confirmation that the cancer is truly at this stage and has not progressed to distant metastases. This often involves comprehensive imaging studies including CT scans of the chest, abdomen, and pelvis, along with bone scans or PET scans to rule out spread to distant organs. These imaging tests create a baseline that can be used later to measure whether the experimental treatment is working.^[14]

Detailed Tumor Characterization

Many clinical trials are designed to test treatments that target specific characteristics of cancer cells. Therefore, detailed laboratory analysis of the tumor tissue becomes essential. Beyond the standard hormone receptor and HER2 testing, trials may require additional molecular testing to identify specific genetic mutations or protein expressions. For instance, some trials focus on cancers with BRCA gene mutations, while others target tumors with specific signaling pathway abnormalities.^[14]

Fresh biopsies may be required for some clinical trials, even if a patient has already had tissue samples taken for initial diagnosis. This is because some molecular tests work best on recently obtained tissue, and trials may need samples processed in specific ways or sent to particular laboratories for analysis.^[7]

Assessment of Overall Health Status

Clinical trials also require thorough evaluation of a patient’s overall health to ensure they can safely receive the experimental treatment. This includes comprehensive blood tests to check kidney function, liver function, and blood cell counts. An electrocardiogram (EKG) and sometimes an echocardiogram assess heart function, which is particularly important if the trial involves drugs that could affect the heart.^[14]

These baseline measurements serve two purposes: they help determine if a patient is healthy enough for the trial, and they provide comparison points to monitor for side effects during treatment. If certain organ systems are already compromised, patients might not be eligible for trials involving drugs that stress those systems further.

Biomarker Testing

Some clinical trials require identification of specific biomarkers—measurable biological indicators that can predict how a cancer will behave or respond to treatment. Blood tests might look for circulating tumor cells or tumor DNA. Tissue samples might be analyzed for the presence of certain proteins or for patterns of gene expression. These tests help match patients with treatments most likely to benefit them based on their cancer’s unique biology.^[7]

Genetic Counseling and Testing

Some patients with stage 3 breast cancer may be referred for genetic counseling and testing for inherited mutations like BRCA1 and BRCA2. While this isn’t required for all clinical trials, certain trials specifically recruit patients with hereditary breast cancers. Additionally, knowing about inherited mutations can influence treatment decisions and has implications for family members who might carry the same genetic changes.^[14]